Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic access to R&E credit may require clarifying legislation, generic industry organizations testify.

Executive Summary

GENERIC DRUG FIRM ACCESS TO R&E TAX CREDIT MAY NEED CLARIFYING LEGISLATION, Harry Gutman of the D.C. office of King & Spalding maintained at a May 10 hearing before the House Ways & Means/Oversight Subcommittee. Gutman testified on behalf of the Generic Pharmaceutical Industry Association, the National Association of Pharmaceutical Manufacturers and the National Pharmaceutical Alliance.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026188

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel